EUVIMEDEUVIMED entdecken
Crossref

Disinhibition of 5-HT1A receptor control by selective 5-HT 1A receptor antagonist WAY-100635: “pharmacological model” to mimic chronic SSRI effects?

Francesco Crespi *

Clinical Research and Clinical Reports · 22.04.2024 · 04 (02) · 01-06

DOI: 10.31579/2835-8325/067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Research and Clinical Reports, online erschienen am 22.04.2024. Verfasst von Francesco Crespi *.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In previous experiments we have been observed that: a) the cyclooxygenase-2 (COX-2) inhibitor 641784 10mg/kg or the selective serotonin reuptake inhibitor (SSRI) paroxetine 5mg/kg reduces cell firing in the Dorsal Raphe Nucleus (RDN) and that their combination shows a larger effect on this parameter. b) 641784 10 mg/kg but not paroxetine 5 is reducing serotonin (5-HT) release in cerebral medial prefrontal cortex (mPFC), and their association does not change the COX-2 inhibitor distinct effect. In the present work the pre-treatment with the selective 5-HT 1A receptor antagonist WAY-100635 30min before 641784 10mg/kg abolishes the reduction of 5-HT release in mPFC observed following the treatment with the COX-2 inhibitor alone. Additionally, the pre-treatment with the selective 5-HT 1A receptor antagonist WAY-100635 30min before paroxetine (5mg/kg) tended to reverse the effect of paroxetine alone on cell firing in RDN. This data may suggest that disinhibition of 5-HT1A receptor control using selective 5-HT 1A receptor antagonist i.e. WAY-100635 could be applied as “pharmacological model” to mimic a chronic SSRI effect.

Zitieren

APA

*, F. C. (2024). Disinhibition of 5-HT1A receptor control by selective 5-HT 1A receptor antagonist WAY-100635: “pharmacological model” to mimic chronic SSRI effects?. Clinical Research and Clinical Reports, 04(02), 01-06. https://doi.org/10.31579/2835-8325/067

Vancouver

* FC. Disinhibition of 5-HT1A receptor control by selective 5-HT 1A receptor antagonist WAY-100635: “pharmacological model” to mimic chronic SSRI effects?. Clinical Research and Clinical Reports. 2024;04(02):01-06. doi:10.31579/2835-8325/067

BibTeX
@article{2024,
  author = {*, Francesco Crespi},
  title = {Disinhibition of 5-HT1A receptor control by selective 5-HT 1A receptor antagonist WAY-100635: “pharmacological model” to mimic chronic SSRI effects?},
  journal = {Clinical Research and Clinical Reports},
  year = {2024},
  volume = {04},
  number = {02},
  pages = {01--06},
  doi = {10.31579/2835-8325/067}
}
Kostenlos starten →